These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Adrenal scintigraphy using 131I-adosterol--as to the usefulness of dexamethasone suppression scintigraphy (author's transl)]. Fukunaga M; Dokoh S; Yamamoto I; Morita R; Torizuka K; Fujita T; Kono T; Tanimura H; Shinpo S Radioisotopes; 1977 Dec; 26(12):864-8. PubMed ID: 605223 [No Abstract] [Full Text] [Related]
3. 131I-6β-iodomethyl-19-norcholesterol adrenal scintigraphy as an alternative to adrenal venous sampling in differentiating aldosterone-producing adenoma from bilateral idiopathic hyperaldosteronism. Saiga A; Yokota H; Nagano H; Sawada K; Kubota Y; Wada T; Horikoshi T; Tanaka T; Uno T Nucl Med Commun; 2020 Dec; 41(12):1226-1233. PubMed ID: 32956247 [TBL] [Abstract][Full Text] [Related]
4. 131I-iodocholesterol (NP-59) scintigraphy in adrenocortical diseases. Taillefer R; Soucy JP; Eybalin MC; Levasseur A J Can Assoc Radiol; 1983 Jun; 34(2):120-4. PubMed ID: 6885882 [TBL] [Abstract][Full Text] [Related]
5. Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia. Fischer M; Vetter W; Winterg B; Zidek W; Vetter H Eur J Nucl Med; 1982; 7(5):222-4. PubMed ID: 7094925 [TBL] [Abstract][Full Text] [Related]
6. Adrenal imaging with 131I-adosterol (NCL-6-131I) by diverging and pinhole methods. III. Comparative studies of baseline and dexamethasone suppression imaging in aldosteronism. Nakajo M Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Apr; 42(4):380-8. PubMed ID: 7122228 [No Abstract] [Full Text] [Related]
8. [The role of adrenal gland x-ray computed tomography and scintigraphy using radiolabelled norcholesterol in the etiological diagnosis of primary hyperaldosteronism]. Abram M; Peltier P; Murat A; Chupin M; Dupas B; Gaillard F; Chatal JF; Charbonnel B Rev Med Interne; 1993; 14(7):691-7. PubMed ID: 8191071 [TBL] [Abstract][Full Text] [Related]
9. Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent. Miles JM; Wahner HW; Carpenter PC; Salassa RM; Northcutt RC Mayo Clin Proc; 1979 May; 54(5):321-7. PubMed ID: 431134 [TBL] [Abstract][Full Text] [Related]
10. 131I-6-iodocholesterol, an agent for imaging the adrenal gland. Jixiao M; Ruisen Z Chin Med J (Engl); 1979 Apr; 92(4):237-46. PubMed ID: 108055 [No Abstract] [Full Text] [Related]
11. [Scintigraphic exploration of the adrenal glands using I-131-6 beta iodomethyl-19-norcholesterol. A practical guide]. Kraimps JL; Bardet S; Nocaudie-Calzada M; Tabarin A; Wémeau JL Ann Chir; 1999; 53(3):255-60. PubMed ID: 10339872 [No Abstract] [Full Text] [Related]
12. The relationship of adrenal gland iodomethylnorcholesterol uptake to zona glomerulosa function in primary aldosteronism. Gross MD; Shapiro B; Grekin RJ; Meyers L; Swanson DP; Beierwaltes WH J Clin Endocrinol Metab; 1983 Sep; 57(3):477-81. PubMed ID: 6874887 [TBL] [Abstract][Full Text] [Related]
13. Location of aldosterone-producing adenomas with 131I-19-iodocholesterol. Hogan MJ; McRae J; Schambelan M; Biglieri EG N Engl J Med; 1976 Feb; 294(8):410-4. PubMed ID: 1246308 [TBL] [Abstract][Full Text] [Related]
14. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy. Gross MD; Shapiro B; Freitas JE J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301 [TBL] [Abstract][Full Text] [Related]
15. The dexamethasone-modified adrenal scintiscan in hyporeninemic aldosteronism (tumor versus hyperplasia). A comparison with adrenal venography and adrenal venous aldosterone. Conn JW; Cohen EL; Herwig KR J Lab Clin Med; 1976 Nov; 88(5):841-56. PubMed ID: 978047 [TBL] [Abstract][Full Text] [Related]
16. Bilateral adrenal tumours in primary aldosteronism: localization of a unilateral aldosteronoma by dexamethasone suppression scan. Hollak CE; Prummel MF; Tiel-van Buul MM J Intern Med; 1991 Jun; 229(6):545-8. PubMed ID: 2045765 [TBL] [Abstract][Full Text] [Related]